IFP Advisors, Inc - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2018$52,000
+62.5%
5,650
+197.4%
0.00%
+200.0%
Q3 2018$32,000
+3.2%
1,900
+5.6%
0.00%0.0%
Q2 2018$31,000
+3000.0%
1,800
+1100.0%
0.00%
Q1 2018$1,0000.0%1500.0%0.00%
Q4 2017$1,000
-50.0%
1500.0%0.00%
Q3 2017$2,000
+100.0%
1500.0%0.00%
Q2 2017$1,000
-50.0%
1500.0%0.00%
Q1 2017$2,000
+100.0%
1500.0%0.00%
Q4 2016$1,0000.0%1500.0%0.00%
Q3 2016$1,000
-75.0%
150
-76.9%
0.00%
Q2 2016$4,000
-42.9%
650
+30.0%
0.00%
Q4 2015$7,0005000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders